![Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram](https://www.researchgate.net/publication/263702696/figure/fig2/AS:667619061411855@1536184196912/Overall-survival-curves-for-A-all-140-patients-with-metastatic-renal-cell-carcinoma-and.png)
Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram
![Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study - European Urology Focus Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/a83a8f70-83e3-42a4-b463-f1a0ccae14a7/gr1.jpg)
Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study - European Urology Focus
![Kaplan-Meier curve depicting the overall survival of 359 metastatic... | Download Scientific Diagram Kaplan-Meier curve depicting the overall survival of 359 metastatic... | Download Scientific Diagram](https://www.researchgate.net/publication/316168352/figure/fig3/AS:670350929039373@1536835524983/Kaplan-Meier-curve-depicting-the-overall-survival-of-359-metastatic-papillary-renal-cell.png)
Kaplan-Meier curve depicting the overall survival of 359 metastatic... | Download Scientific Diagram
![Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-49250-6/MediaObjects/41598_2019_49250_Fig2_HTML.png)
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
![Efficacy and Safety of Axitinib Therapy After Nivolumab for Patients With Metastatic Renal Cell Cancer | Anticancer Research Efficacy and Safety of Axitinib Therapy After Nivolumab for Patients With Metastatic Renal Cell Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/11/6493/F1.large.jpg)
Efficacy and Safety of Axitinib Therapy After Nivolumab for Patients With Metastatic Renal Cell Cancer | Anticancer Research
![Cancers | Free Full-Text | Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma Cancers | Free Full-Text | Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma](https://pub.mdpi-res.com/cancers/cancers-11-01000/article_deploy/html/images/cancers-11-01000-g001.png?1564745632)
Cancers | Free Full-Text | Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma
![Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis](https://www.jcancer.org/v11/p7202/jcav11p7202g001.jpg)
Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis
![Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon-2020-1020/asset/images/medium/figure2.gif)
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
![Cureus | Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma? | Article Cureus | Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma? | Article](https://assets.cureus.com/uploads/figure/file/145768/lightbox_21f1d720f98711eaa1404b0b7b21a436-1article_river_53022740f14c11ea96e5d70f6283b195-figure-1.png)
Cureus | Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma? | Article
![Management of poor-risk metastatic renal cell carcinoma: current approaches, the role of temsirolimus and future directions | Future Oncology Management of poor-risk metastatic renal cell carcinoma: current approaches, the role of temsirolimus and future directions | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.15.313/asset/images/medium/figure2.gif)
Management of poor-risk metastatic renal cell carcinoma: current approaches, the role of temsirolimus and future directions | Future Oncology
![Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study | Journal for ImmunoTherapy of Cancer | Full Text Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study | Journal for ImmunoTherapy of Cancer | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs40425-018-0420-0/MediaObjects/40425_2018_420_Fig2_HTML.png)
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study | Journal for ImmunoTherapy of Cancer | Full Text
![Changes in therapy and survival of metastatic renal cell carcinoma in Estonia | BMC Cancer | Full Text Changes in therapy and survival of metastatic renal cell carcinoma in Estonia | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-6685-y/MediaObjects/12885_2020_6685_Fig1_HTML.png)
Changes in therapy and survival of metastatic renal cell carcinoma in Estonia | BMC Cancer | Full Text
![Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram](https://www.researchgate.net/publication/7781128/figure/fig2/AS:601588360032308@1520441250678/Overall-survival-for-patients-with-progressive-metastatic-renal-cell-carcinoma-treated.png)
Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram
![Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors](https://www.mdpi.com/cancers/cancers-12-00084/article_deploy/html/images/cancers-12-00084-g001.png)
Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
![Frontiers | Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice Frontiers | Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice](https://www.frontiersin.org/files/Articles/657639/fonc-11-657639-HTML/image_m/fonc-11-657639-g001.jpg)
Frontiers | Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice
![Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation](https://www.frontiersin.org/files/Articles/762547/fonc-11-762547-HTML/image_m/fonc-11-762547-g001.jpg)